In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation
about
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.Tuning the specificity of a Two-in-One Fab against three angiogenic antigens by fully utilizing the information of deep mutational scanning.Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.Modular protein expression by RNA trans-splicing enables flexible expression of antibody formats in mammalian cells from a dual-host phage display vector.Antibody therapies for the prevention and treatment of viral infections.Antibody Affinity and Stability Maturation by Error-Prone PCR.
P2860
In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In vitro affinity maturation o ...... to in vivo affinity maturation
@ast
In vitro affinity maturation o ...... to in vivo affinity maturation
@en
type
label
In vitro affinity maturation o ...... to in vivo affinity maturation
@ast
In vitro affinity maturation o ...... to in vivo affinity maturation
@en
prefLabel
In vitro affinity maturation o ...... to in vivo affinity maturation
@ast
In vitro affinity maturation o ...... to in vivo affinity maturation
@en
P2093
P2860
P356
P1476
In vitro affinity maturation o ...... to in vivo affinity maturation
@en
P2093
Ashley E Fouts
Becket Feierbach
Katharina Stengel
Michael Dillon
Robert F Kelley
Wei-Ching Liang
P2860
P304
P356
10.4161/MABS.27875
P50
P577
2014-01-16T00:00:00Z